← Open Payments lookup

USHA ALAGESAN: Open Payments

NPI 1871928572 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,160 in 67 payments from 17 companies in 2025. Trend: 2023 $675 · 2024 $1,107 · 2025 $1,160

Food & beverage: $1,160
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$206
Phathom Pharmaceuticals, Inc.13$149
Janssen Biotech, Inc.6$117
Braintree Laboratories, Inc.4$95
Takeda Pharmaceuticals U.S.A., Inc.4$92
Ardelyx, Inc.4$75
PFIZER INC.4$60
Lilly USA, LLC3$58
ABBVIE INC.3$57
Madrigal Pharmaceuticals3$55

Products named: XIFAXAN, VOQUEZNA, TREMFYA, SUFLAVE, ENTYVIO, IBSRELA, OMVOH, RINVOQ.

Industry payments across NJ — which companies pay providers there.